| 51.94 Data as of 4:00pm ET |  +0.91 / +1.78%Today’s Change | 24.80 Today|||52-Week Range 58.07 | +41.43% Year-to-Date |
| The Best Healthcare Bet 12:36pm / MotleyFool.com | Gilead Interim Phase 2 Data for Idelalisib Shows Response in Refractory Indolent Non-... Jun 17 / Benzinga |
| Todaybs 3 Worst Stocks Jun 17 / MotleyFool.com | Biotech Stock Mailbag: Exact Sciences, Questcor, Biotech M&A, Celsion Jun 14 / TheStreet.com |
| Warning: This Might Be The Most Overvalued Sector In The Market Jun 17 / Street Authority | Thursday's Top Upgrades (and Downgrades) Jun 13 / MotleyFool.com |
| Gilead Sciences Inc (GILD): Today's Featured Drugs Laggard Jun 17 / TheStreet.com | Inside HCV: An Interview with Janssen Jun 12 / MotleyFool.com |
| Huge Upside on Pipeline Strength Jun 17 / MotleyFool.com | Game-Changing Hep C Pill Closer to Approval Jun 11 / MotleyFool.com |
| Previous close | 51.03 |
| Today’s open | 50.87 |
| Day’s range | 50.87 - 52.05 |
| Volume | 6,874,024 |
| Average volume (3 months) | 12,227,815 |
| Market cap | $77.8B |
| Dividend yield | -- |
| Earnings growth (last year) | -7.61% |
| Earnings growth (this year) | +0.70% |
| Earnings growth (next 5 years) | +29.00% |
| Revenue growth (last year) | +13.58% |
| P/E ratio | 29.0 |
| Price/Sales | 5.79 |
| Price/Book | 8.33 |
| Today’s change | Today’s % change | |
|---|---|---|
| AMGNAmgen Inc | +2.42 | +2.44% |
| BIIBBiogen Idec Inc | +3.05 | +1.47% |
| BAXBaxter International... | +0.15 | +0.21% |
| LIFELife Technologies Co... | +0.03 | +0.04% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $0.50 |
| Annual revenue (last year) | $9.6B |
| Annual profit (last year) | $2.6B |
| Net profit margin | 26.96% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer John C. Martin, PhD, MBA |
President & Chief Operating Officer John F. Milligan, PhD |
Corporate headquarters Foster City, California |
.
